A 70-year-old female patient has just been diagnosed with Alzheimer's disease. Which of the following drug is used for the treatment of Alzheimer's disease?
bethanechol (Urecholine)
albuterol (Proventil)
rivastigmine
edrophonium (Enlon)
The Correct Answer is C
A. Bethanechol (Urecholine)
Bethanechol is a cholinergic agonist used to treat urinary retention. It is not indicated for Alzheimer's disease.
B. Albuterol (Proventil)
Albuterol is a bronchodilator used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is not indicated for Alzheimer's disease.
C. Rivastigmine
Rivastigmine is a medication commonly used for the treatment of Alzheimer's disease. It belongs to a class of drugs called cholinesterase inhibitors, which work by increasing the levels of acetylcholine in the brain. This can help improve cognitive function in individuals with Alzheimer's disease.
D. Edrophonium (Enlon)
Edrophonium is a medication used for the diagnostic evaluation of Myasthenia Gravis. It is not used in the treatment of Alzheimer's disease.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Increase the amount of dopamine and reduce the amount of acetylcholine:
This is the correct answer. Parkinson's disease is characterized by a deficiency of dopamine, so medications aim to increase dopamine levels. Additionally, reducing the activity of acetylcholine helps to restore the balance between these neurotransmitters.
B. Increase the amount of dopamine and acetylcholine:
This is not accurate. Increasing both dopamine and acetylcholine would not address the underlying imbalance seen in Parkinson's disease.
C. Reduce the amount of dopamine and increase the amount of acetylcholine:
This is incorrect. Parkinson's disease involves a reduction in dopamine levels, so reducing dopamine further would worsen the symptoms. Additionally, increasing acetylcholine is not the therapeutic goal in Parkinson's disease.
D. Reduce the amount of dopamine and acetylcholine:
This is not the correct approach. Decreasing both dopamine and acetylcholine would exacerbate the symptoms of Parkinson's disease, as the primary issue is the deficiency of dopamine.
Correct Answer is ["A","D"]
Explanation
A. Blood dyscrasias: This is a correct choice. Phenytoin can cause blood dyscrasias, including conditions like leukopenia, thrombocytopenia, and anemia.
B. Hyperglycemia: This is not typically associated with phenytoin. The primary adverse effects related to blood sugar are usually changes in glucose metabolism or hypoglycemia.
C. Urinary retention: This is not a common adverse effect of phenytoin. It is more associated with other medications or medical conditions.
D. Gingival hyperplasia: This is a correct choice. Phenytoin is known to cause gingival hyperplasia, which is an overgrowth of the gum tissue.
E. Sedation: This is not a common adverse effect of phenytoin. Phenytoin is more known for causing CNS-related side effects like nystagmus, ataxia, and dizziness.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.